These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26949990)

  • 1. Infection in cystic fibrosis: impact of the environment and climate.
    Ramsay KA; Stockwell RE; Bell SC; Kidd TJ
    Expert Rev Respir Med; 2016; 10(5):505-19. PubMed ID: 26949990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M
    Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculous mycobacterial infections in cystic fibrosis.
    Martiniano SL; Nick JA
    Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry.
    Gardner AI; McClenaghan E; Saint G; McNamara PS; Brodlie M; Thomas MF
    Clin Infect Dis; 2019 Feb; 68(5):731-737. PubMed ID: 29982302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.
    Bouso JM; Burns JJ; Amin R; Livingston FR; Elidemir O
    Pediatr Pulmonol; 2017 Mar; 52(3):324-330. PubMed ID: 28135043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
    Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
    Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
    J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.
    Prevots DR; Adjemian J; Fernandez AG; Knowles MR; Olivier KN
    Ann Am Thorac Soc; 2014 Sep; 11(7):1032-8. PubMed ID: 25068620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model.
    Le Moigne V; Rottman M; Goulard C; Barteau B; Poncin I; Soismier N; Canaan S; Pitard B; Gaillard JL; Herrmann JL
    Vaccine; 2015 Apr; 33(18):2118-24. PubMed ID: 25804706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis.
    Abidin NZ; Gardner AI; Robinson HL; Haq IJ; Thomas MF; Brodlie M
    J Cyst Fibros; 2021 Sep; 20(5):737-741. PubMed ID: 32950411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.
    Mussaffi H; Rivlin J; Shalit I; Ephros M; Blau H
    Eur Respir J; 2005 Feb; 25(2):324-8. PubMed ID: 15684298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis.
    Psoter KJ; De Roos AJ; Mayer JD; Kaufman JD; Wakefield J; Rosenfeld M
    Ann Am Thorac Soc; 2015 Mar; 12(3):385-91. PubMed ID: 25594356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which pathogens should we worry about?
    Jones AM
    Paediatr Respir Rev; 2019 Aug; 31():15-17. PubMed ID: 30967346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
    Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
    BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
    Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
    J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium abscessus and other nontuberculous mycobacteria: evolving respiratory pathogens in cystic fibrosis: a case report and review.
    Hayes D
    South Med J; 2005 Jun; 98(6):657-61. PubMed ID: 16004174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.